1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Age-Friendly Minnesota Grants (Community Grants) is sponsored by Age-Friendly Minnesota Council / Minnesota Department of Human Services (DHS). These grants support a wide range of age-friendly projects to make Minnesota a better place for all to grow older. Community Grants fund various project types with a focus on systems and environmental change, rather than direct services.
This includes initiatives that foster health, well-being, and other ways to improve aging.
Get alerted about grants like this
Get emailed when new opportunities from “Age-Friendly Minnesota Council / Minnesota Department of Human Services (DHS)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Cities, nonprofit organizations, for-profit businesses, and others. Confirm the full requirements in the official notice before applying.
The current listing shows grants ranging from $9,000 to $75,000 (total of $1.3 million awarded in previous rounds). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Age-Friendly Minnesota Grants (Community Grants) is funded by Age-Friendly Minnesota Council / Minnesota Department of Human Services (DHS). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
OSTP's July 21 Golden Age report and budget memo redirect ~$200B in federal R&D toward individual scientists and AI. Here's who wins and how to position.
Read articleThe STOMP program funds measurement tools and removal therapies for microplastics in human tissue. Proposals due June 22. Eligibility, phases, and strategy.
Read articleThe Complement-ARIE program funds seven technology centers to develop human-based models that complement animal research. What it means for drug developers, academic researchers, and the regulatory pipeline.
Read article